Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Optibrium Introduces StarDrop 5.4 to Target Novel, Safe and Efficacious Drugs

Published: Tuesday, June 11, 2013
Last Updated: Tuesday, June 11, 2013
Bookmark and Share
Next generation software adds modules for knowledge-based prediction of toxicity and application of over 20,000 bioisosteric transformations.

Optibrium announced the release of version 5.4 of its StarDrop™ software platform. This new release offers enhanced features to guide the design of novel, safe and efficacious drugs by providing access to world-leading technologies for toxicity prediction and bioisosteric transformations. These new optional modules further extend StarDrop’s capabilities to intuitively target high quality compounds in drug discovery, reducing the time and cost to deliver drug candidates with an improved chance of success.

The new Derek Nexus™ module for StarDrop, developed in collaboration with Lhasa Limited, provides knowledge-based predictions of the likelihood of a compound causing toxicity in over 40 endpoints, including mutagenicity, carcinogenicity and hepatotoxicity. Seamlessly integrated with StarDrop’s Glowing Molecule™ visualisation, this new module guides the redesign of compounds to reduce the potential for toxicity. An easy-to-use reporting feature facilitates collaboration between chemists and expert toxicologists to interpret the results, enabling effective, timely decision-making regarding the prioritisation of chemistries early in the drug discovery process.

Stimulating the search for new optimisation strategies, the BIOSTER™ module extends StarDrop’s existing Nova™ module that generates new compound ideas, prioritised against a project’s required property profile. The BIOSTER module, developed with Digital Chemistry, adds over 20,000 precedented bioisosteric transformations, which Nova can use to generate a broad range of novel structures. This database has been expertly curated from the scientific literature, with citations to the original source material facilitating further chemical and biological validation of the new ideas. The combination of Nova and BIOSTER provides access to a wealth of chemical experience to generate strategies for exploration of hits, lead hopping and patent protection.

In addition, StarDrop 5.4 also sees further enhancements of its existing functionality. The renamed torch3D module, using Cresset’s unique Field technology to understand and apply 3D Structure Activity Relationship (SAR), has been updated to include the latest version of Cresset’s XED force field providing insight into compounds’ 3D structures, biological activities and interactions. The data visualisation component of StarDrop also receives a major upgrade, introducing new interactive plot types and increased flexibility to visualise and explore structure-activity relationships.

Dr Matthew Segall, Optibrium’s CEO, commented, “We are very pleased to release this exciting new version of StarDrop, including new modules developed with our partners, so soon after announcing our collaborations with Lhasa Limited and Digital Chemistry. This reinforces our commitment to work with the wider community of developers to deliver world-leading technologies which seamlessly integrate with our unique in-house technology in StarDrop’s intuitive user interface.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Optibrium, The Edge Collaborate on Integration of StarDrop with BioRails
The combination provides an enterprise platform for comprehensive data management, analysis and compound design in drug discovery.
Tuesday, September 20, 2016
BioSolveIT and Optibrium Sign Collaboration Agreement
Partnership will deliver a link between 2D and 3D design on medicinal chemists’ desktops.
Tuesday, October 20, 2015
Optibrium Joins HeCaToS Project and Expands R&D Team
The Hepatic and Cardiac Toxicity Systems project is a major European project with the objective to efficiently investigate the health impact of compounds on the heart and liver.
Tuesday, October 08, 2013
Optibrium and Digital Chemistry Announce Technology Collaboration
Integration of bioisostere database with automatic application and prioritisation will guide the identification of successful, novel, high quality compounds in drug discovery.
Friday, December 14, 2012
Optibrium and Cresset Announce Technology Collaboration
Technology exchange combines unique methods for design of novel, high quality compounds in drug discovery.
Thursday, January 05, 2012
Scientific News
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Adipose Tissue Secretes Factors That Activate Metabolism
Study finds brown adipose tissue secretes signalling factors that activates metabolism of fat and carbohydrates.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Developing Novel Ear Infection Treatments
Research team engineers antibiotic gel for treating middle ear infections.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!